ロード中...
Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole
The endocrine therapy is the new frontiers of many breast cancers hormone sensitive. Hormone therapy for treating women with hormone receptor-positive cancer suppresses breast cancer growth either by reducing estrogen synthesis or by interfering with the action of estrogen within tumor cells. In thi...
保存先:
出版年: | Front Pharmacol |
---|---|
主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Frontiers Media S.A.
2017
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5601069/ https://ncbi.nlm.nih.gov/pubmed/28955236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00632 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|